ArticlePediatric cardiology2026
Pulmonary Venous Decompressing Collaterals: Angiographic Characteristics and Impact on Outcomes in Pediatric Pulmonary Vein Stenosis.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric pulmonary vein stenosis (PVS) is a rare, progressive condition associated with significant morbidity and mortality. While pulmonary venous decompressing collaterals (PVDC) have been described, their clinical relevance and impact on long-term outcomes remain unstudied. We aimed to characterize these collaterals and determine their association with outcomes and mortality in pediatric PVS. This was a single-center, retrospective cohort study of 64 pediatric patients (≤ 18 years) treated for PVS between 2017 and 2022. Patients with single-ventricle heart disease were excluded. PVDC were defined as contrast flow to a neighboring lobar or interlobar segment due to medial occlusion identified on serial angiograms. The primary outcome was PVS-related mortality analyzed using multivariable Cox proportional hazards models, adjusting for age and gestational age. PVDC were present in 39/64 (61%) patients. The presence of collaterals was significantly associated with lower all-cause (15% vs. 40%, p = 0.027) and PVS-related mortality (13% vs. 40%, p = 0.012). This benefit was most pronounced in the bilateral disease subgroup (45% of the cohort). In this group, patients with collaterals had significantly lower PVS-related mortality (15% vs. 78%, p = 0.002) and lower indexed pulmonary vascular resistance (iPVR 3.2 vs. 7.6 Wood unit x m
Indexed as
Identifiers
42435212What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.